Langerhans cell histiocytosis: Presentation in a preterm neonate
Authors:
Open Access
- 22 June 2021
- journal article
- case report
- Published by Wiley in Cancer Reports
- Vol. 5 (2) , e1472
Abstract
Background: Langerhans cell histiocytosis (LCH) is a rare disorder in which Langerhans cells (LC) accumulate in the skin or other organs and cause tumor formation or organ damage. Cutaneous lesions can vary widely and do not predict extent of systemic disease or prognosis.Case: We present a premature infant with skin findings, multisystem involvement, and immunohistochemical markers consistent with multisystem LCH.Conclusion: Limited data from preterm neonates with LCH suggest that prognosis is particularly poor, with even limited cutaneous disease often rapidly progressing to become fatal, although diagnosis is not always prompt. Early diagnosis and treatment may affect prognosis.Keywords
This publication has 22 references indexed in Scilit:
- Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 yearsPediatric Blood & Cancer, 2012
- Recent advances in the understanding of Langerhans cell histiocytosisBritish Journal of Haematology, 2011
- Multisystem Langerhans Cell Histiocytosis in ChildrenPediatric Drugs, 2011
- Cutaneous Metastases in Neonates: A ReviewPediatric Dermatology, 2011
- Langerhans cell histiocytosis in a premature baby presenting with skin‐isolated disease: case report and literature reviewActa Paediatrica, 2008
- Langerhans Cell Histiocytosis: A Review of the Current Recommendations of the Histiocyte SocietyPediatric Dermatology, 2008
- Congenital systemic Langerhans cell histiocytosis presenting as hydrops fetalisActa Paediatrica, 2005
- Langerhans cell histiocytosis in neonatesPediatric Blood & Cancer, 2005
- Langerhans Cell Histiocytosis Presenting in the Neonatal PeriodArchives of Pediatrics & Adolescent Medicine, 2001
- Leukemia Cutis in Congenital LeukemiaArchives of Dermatology, 1993